UK health data, menopause support and social media censorship: The societal shifts of October 2026
From NHS trusts rejecting Palantir’s patient data platform to Instagram’s shadowbanning of women’s health content, UK society grapples with technology’s role in care—and who controls it.
The NHS’s quiet rebellion against Palantir’s data platform
The UK’s healthcare system is fracturing over a £330m patient data platform operated by Palantir, the US technology firm whose work with intelligence agencies has long drawn scrutiny. While some NHS trusts praise the federated data platform (FDP) for streamlining surgery schedules and managing waiting lists, others are walking away—citing concerns over functionality, cost, and the company’s controversial reputation.
Freedom of Information requests reveal a patchwork of responses across England. In Suffolk, one trust declared existing systems “supercede” the FDP’s capabilities, while Greater Manchester’s integrated care board abandoned trials after finding no clear advantage. Gateshead and Truro have similarly opted out, raising questions about whether the platform’s rollout has been driven more by political urgency than clinical need.
The divide reflects broader tensions in the NHS’s digital transformation. Proponents argue the FDP could reduce administrative burdens, but critics warn of a creeping privatisation of patient data. With no central mandate forcing adoption, the platform’s future now hinges on whether trusts can be convinced—or compelled—to integrate it.
Menopause support goes digital as stigma persists
On World Menopause Day, an online forum organised by Menopause Matters is offering a rare space for discussion in a country where the topic remains taboo. The event, held this Sunday, arrives as new research underscores the financial and emotional toll of menopause on UK women: a 2025 study by the Fawcett Society found that one in ten women had left their jobs due to symptoms, costing the economy an estimated £10bn annually.
Yet even as awareness grows, access to support remains uneven. A survey by the British Menopause Society last month revealed that 45% of women had never discussed menopause with their GP, while 30% reported being dismissed when they did. The online forum, which includes sessions on pain management and workplace adjustments, reflects a shift toward community-led solutions—particularly for women in rural areas or those unable to access specialist clinics.
The timing is critical. The UK’s first Menopause Taskforce, launched in 2024, has yet to deliver concrete policy changes, leaving charities and digital platforms to fill the gap. For now, the burden of advocacy still falls on women themselves.
Social media’s war on women’s health language
Instagram’s algorithms are censoring content about pregnancy, menopause, and even the word “vagina,” according to creators who say their posts are being shadowbanned or removed without explanation. The issue, which first gained attention in 2023, has resurfaced as influencers and health organisations report a surge in takedowns—including ads for a business that used the word “pregnancy” in its promotional material.
Meta, Instagram’s parent company, has long defended its policies as necessary to prevent misinformation. But critics argue the platform’s automated systems are incapable of distinguishing between medical content and explicit material. A 2026 report by the Centre for Countering Digital Hate found that posts about endometriosis and postpartum recovery were three times more likely to be flagged than those about erectile dysfunction.
The censorship extends beyond Instagram. TikTok and Facebook have faced similar accusations, with users reporting that terms like “menstruation” and “pelvic pain” trigger restrictions. The pattern has alarmed public health experts, who warn that silencing discussions about women’s health could exacerbate existing disparities in care.
Australia has proposed a radical solution: a legal “off switch” for algorithmic recommendations, allowing users to opt out of content curation entirely. Whether the UK will follow remains unclear—but for now, women’s health advocates are left navigating a digital landscape where even basic terminology is treated as suspect.
What to watch
- NHS data divide: Will the government intervene to standardise Palantir’s adoption, or allow trusts to chart their own paths?
- Menopause policy: The Women and Equalities Committee is due to publish its report on workplace support next month. Expect pressure on employers to act.
- Algorithmic accountability: The Online Safety Act’s review of automated moderation could force platforms to clarify their rules—or face fines.
